Literature DB >> 24165911

Prevention: Rosuvastatin can prevent contrast-induced AKI.

Alexandra Roberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24165911     DOI: 10.1038/nrcardio.2013.166

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).

Authors:  Mario Leoncini; Anna Toso; Mauro Maioli; Francesco Tropeano; Simona Villani; Francesco Bellandi
Journal:  J Am Coll Cardiol       Date:  2013-09-26       Impact factor: 24.094

2.  Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

Authors:  Yaling Han; Guoying Zhu; Lixian Han; Fengxia Hou; Weijian Huang; Huiliang Liu; Jihong Gan; Tiemin Jiang; Xiaoyan Li; Wei Wang; Shifang Ding; Shaobin Jia; Weifeng Shen; Dongmei Wang; Ling Sun; Jian Qiu; Xiaozeng Wang; Yi Li; Jie Deng; Jing Li; Kai Xu; Bo Xu; Roxana Mehran; Yong Huo
Journal:  J Am Coll Cardiol       Date:  2013-09-26       Impact factor: 24.094

  2 in total
  1 in total

1.  HDL Cholesterol Level Is Associated with Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing PCI.

Authors:  Hoon Suk Park; Chan Joon Kim; Byung-Hee Hwang; Tae-Hoon Kim; Yoon Seok Koh; Hun-Jun Park; Sung-Ho Her; Sung Won Jang; Chul-Soo Park; Jong Min Lee; Hee-Yeol Kim; Doo Soo Jeon; Pum-Joon Kim; Ki-Dong Yoo; Kiyuk Chang; Dong Chan Jin; Ki-Bae Seung
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.